Interestingly, the frequency of FOXA1 mutation varies with ethnic background, with a striking finding of FOXA1 mutations in 41% of localized prostate tumors within the Chinese Prostate Cancer Genome and Epigenome Atlas (CPGEA), which is significantly higher than western cohorts [11]. The gene discussed is FOXA1; the disease is prostate carcinoma.